Electromed Stock In The News
| ELMD Stock | USD 13.94 0.19 1.34% |
The tone or emotional content of news articles related to Electromed can affect its prices. Positive news sentiment can lead to an increase in demand for Electromed's stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Electromed's news coverage and content from conventional and social sources shows investors' bearish mood towards Electromed. The specific impact of Electromed news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Electromed's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Electromed headlines in addition to utilizing other, more conventional financial analysis modules. Check out Electromed Backtesting and Electromed Hype Analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
Electromed |
Electromed Today Top News and Investor Outlook
Electromed Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Electromed and other traded companies coverage. We help investors stay connected with Electromed headlines for the 18th of April 2024 to make an informed investment decision based on correlating the impacts of news items on Electromed Stock performance. Please note that trading solely based on the Electromed hype is not for everyone as timely availability and quick action are needed to avoid losses.Electromed stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Electromed earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Electromed that are available to investors today. That information is available publicly through Electromed media outlets and privately through word of mouth or via Electromed internal channels. However, regardless of the origin, that massive amount of Electromed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Electromed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Electromed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Electromed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Electromed alpha.
Electromed Largest EPS Surprises
Earnings surprises can significantly impact Electromed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2012-02-13 | 2011-12-31 | 0.01 | 0.003 | -0.007 | 70 | ||
2021-11-09 | 2021-09-30 | 0.06 | 0.05 | -0.01 | 16 | ||
2020-05-12 | 2020-03-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2016-11-08 | 2016-09-30 | 0.03 | 0.02 | -0.01 | 33 | ||
2016-09-06 | 2016-06-30 | 0.05 | 0.04 | -0.01 | 20 | ||
2016-05-10 | 2016-03-31 | 0.07 | 0.06 | -0.01 | 14 |
Electromed Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Electromed Stock. The global stock market is bullish. About 66% of major world exchanges and indexes are currently up. See today's market update for more information.
15th of April 2024
Integer Holdings upgraded to Buy at BofA Research on PFA opportunity at seekingalpha.com
12th of April 2024
Is NeuroPace Weighed On By Its Debt Load at simplywall.st
11th of April 2024
Electromed Upgraded to Strong-Buy at StockNews.com - Defense World at news.google.com
10th of April 2024
Social media bans are old newsnow the U.K. is considering banning phone sales to kids unde... at fortune.com
10th of April 2024
Should You Invest in CONMED at insidermonkey.com
9th of April 2024
Paragon 28 Shares Up 4.7 percent - MarketBeat at news.google.com
4th of April 2024
Sidoti Events, LLCs Virtual June Small-Cap Conference - The Globe and Mail at news.google.com
4th of April 2024
OrthoPediatrics Corp. to Highlight its Pediatric Scoliosis Solutions at 8th Annual Interna... at globenewswire.com
4th of April 2024
Paragon 28 gives prelim Q1 numbers, announces CFO transition at seekingalpha.com
4th of April 2024
Analysts Expect Breakeven For AxoGen, Inc. Before Long at finance.yahoo.com
3rd of April 2024
IRADIMED files to offer common stock at seekingalpha.com
2nd of April 2024
Acquisition by Stephanie Bolton of 4915 shares of LivaNova PLC subject to Rule 16b-3 at benzinga.com
2nd of April 2024
Pulmonx names new CFO to bolster financial leadership at investing.com
2nd of April 2024
Sight Sciences reports positive long-term glaucoma treatment data at investing.com
1st of April 2024
IRadimed shares get price target bump on growth outlook at investing.com
1st of April 2024
Are You a Value Investor This 1 Stock Could Be the Perfect Pick at finance.yahoo.com
28th of March 2024
Reports Cement truck driver admitted using cocaine the morning of deadly Texas school bus ... at hawaiinewsnow.com
28th of March 2024
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler R3I... at businesswire.com
27th of March 2024
Prosomnus, Inc. Navigating Market Volatility and Liquidity Risks Post-Merger - TipRanks.co... at news.google.com
26th of March 2024
Florida Social Media Ban For Kids to Take Effect on January 2025 at techtimes.com
26th of March 2024
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results at finance.yahoo.com
26th of March 2024
Axogens chief innovation officer sells over 35k in stock at investing.com
25th of March 2024
Does Neuropace Inc Have What it Takes to be in Your Portfolio Monday - InvestorsObserver at news.google.com
22nd of March 2024
Levi Korsinsky Reminds Shareholders of an Investigation into Orthofix Medical Inc. Regardi... at accesswire.com
22nd of March 2024
Public Employees Retirement System of Ohio Grows Position in CONMED Co. - Defense World at news.google.com
20th of March 2024
Heres Why You Should Hold Surmodics Stock for Now - Zacks Investment Research at news.google.com
20th of March 2024
LivaNova gains after positive predictive outcome of sleep apnea study at seekingalpha.com
20th of March 2024
Pulmonx Corp LUNG Investment Appeal on the Rise Knox Daily - Knox Daily at news.google.com
20th of March 2024
3384 Shares in Integer Holdings Co. Acquired by Graham Capital Management L.P. - Defense W... at news.google.com
19th of March 2024
Artivion, Inc. VP Sells 29240.00 in Stock - Defense World at news.google.com
18th of March 2024
Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer at finance.yahoo.com
18th of March 2024
Disposition of 90000 shares by Marc Began of Axogen at 8.16 subject to Rule 16b-3 at MacroaxisInsider
14th of March 2024
Global Waterjet Cutting Machines Market Size is projected to reach USD 1,340.60 million by... at finance.yahoo.com
12th of March 2024
LivaNova PLCs Stock Is Going Strong Have Financials A Role To Play at simplywall.st
12th of March 2024
Is Artivion Stock Outpacing Its Medical Peers This Year at finance.yahoo.com
11th of March 2024
Disposition of 90000 shares by Marc Began of Axogen at 8.16 subject to Rule 16b-3 at thelincolnianonline.com
8th of March 2024
Acquisition by Erik Mickelson of 15455 shares of Paragon 28 subject to Rule 16b-3 at MacroaxisInsider
8th of March 2024
Sight Sciences Inc Navigates Challenges to Maintain Revenue Growth and Reduce Expenses at finance.yahoo.com
7th of March 2024
NeuroPace, Inc. Q4 2023 Earnings Call Transcript at finance.yahoo.com
5th of March 2024
NeuroPace Announces Record Full Year 2023 Revenue of 65.4 Million at globenewswire.com
5th of March 2024
Acquisition by David Lehman of 34500 shares of PulmonxCorp subject to Rule 16b-3 at MacroaxisInsider
4th of March 2024
IRadimed Full Year 2023 Earnings In Line With Expectations at simplywall.st
1st of March 2024
Acquisition by James Cunniff of 9000 shares of Electromed at 15.25 subject to Rule 16b-3 at James Cunniff
1st of March 2024
Disposition of tradable shares by Vladimir Makatsaria of LivaNova PLC subject to Rule 16b-... at MacroaxisInsider
29th of February 2024
Electromed Soars with Composite Rating Jump to 96, Outperforming 96 percent of Stocks - BN... at news.google.com
27th of February 2024
Pulmonx meldet Behandlung des ersten Patienten mit dem AeriSeal-System in der CONVERT-II-Z... at businesswire.com
26th of February 2024
Analyzing Shockwave Medical and Surmodics at thelincolnianonline.com
22nd of February 2024
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2... at benzinga.com
21st of February 2024
Is Electromed Inc a Leader in the Healthcare Sector - InvestorsObserver at news.google.com
15th of February 2024
Acquisition by Len Liptak of 1322756 shares of ProSomnus Common subject to Rule 16b-3 at MacroaxisInsider
15th of February 2024
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results at prnewswire.com
14th of February 2024
Electromed Inc Up 20.49 percent To 12.35 After Earnings Beat - InvestorsObserver at news.google.com
9th of February 2024
IRadimed Corporation Q4 2023 Earnings Call Transcript at finance.yahoo.com
2nd of February 2024
Surmodics First Quarter 2024 Earnings Beats Expectations at simplywall.st
30th of January 2024
Electromed, Inc. Schedules its Second Quarter Fiscal 2024 Financial Results Conference Cal... at news.google.com
24th of January 2024
Akkos Magnetic Switch Keyboard Could Be The Ultimate Gaming Weapon at forbes.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Electromed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Electromed's short interest history, or implied volatility extrapolated from Electromed options trading.
Check out Electromed Backtesting and Electromed Hype Analysis. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Electromed Stock analysis
When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.727 | Earnings Share 0.45 | Revenue Per Share 6.072 | Quarterly Revenue Growth 0.167 | Return On Assets 0.0721 |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.